Mary Kay Fenton - Apr 29, 2024 Form 3 Insider Report for Cullinan Therapeutics, Inc. (CGEM)

Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Stock symbol
CGEM
Transactions as of
Apr 29, 2024
Transactions value $
$0
Form type
3
Date filed
4/30/2024, 08:58 PM
Previous filing
Jul 6, 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24 - Power of Attorney